LETTER
Asymmetric Synthesis of (R)- and (S)-Cizolirtine via CBS Reduction
767
(13) A typical experimental procedure is as follows: To a stirred
solution of (R)-(+)-2-methyl-CBS-oxazaborolidine 1M in
toluene (7.5 mL, 7.5 mol) under argon cooled to -10° C, a
solution of catecholborane 1M in THF (100 mL, 100 mmol)
was slowly added. To the mixture was then added a solution
of 5-benzoyl-1-methyl-1H-pyrazole 2 (9.30 g, 50 mmol) in
dry toluene (100 mL) and the reaction was stirred 1 h a
-15° C and 20 h at room temperature. MeOH (10 mL) was
added carefully with stirring for 2 h. The mixture was
concentrated at reduced pressure to 100 mL, washed
successively with water, HCl 1N and brine, dried and
evaporated to give an oil which was purified by silicagel
column chromatography, using ethyl acetate: petroleum ether
(7:3) as eluent to afford (R)-(+)-1-methyl-a-phenyl-1H-
pyrazole-5-methanol (R)-3 in 98% ee (7.82 g, 83%).; mp:
81-83° C; [a]D= +16.6 (c= 1.02, CHCl3).
It is noteworthy that the difference in steric bulk of benz-
imidazole ring versus pyrazole of ketone 2 did not affect
the enantioselective site of the reaction. In both cases the
(R)-carbinol was obtained confirming that in these two ex-
amples the heterocyclic ring behaves as the small group.
In conclusion, we have achieved the asymmetric synthesis
of the enantiomers of cizolirtine with high enantiomeric
excess. The application of CBS reduction to other het-
eroaryl phenyl ketones will be further investigated.
Acknowledgement
We thank Dr. Jordi Quintana for performing the molecular mecha-
nics calculations.
(14) Enantiomeric excess determined on a Chiralcel OD-H column
at l= 230 nm; flow rate: 1 mL/min; eluent: hexane: i-PrOH
(93:7) with 0.1% diethylamine.
References and Notes
(15) The structure of 2 was optimized by molecular mechanics
using the modelling software Chem-X (Chemical Design Ltd.,
UK). The calaculated distance between carbonyl oxygen and
pyrazole N-2 increased from 4.21 Å in the planar structure to
4.46 Å in the optimized structure.
(16) During the preparation of this manuscript an unsuccessful
attempt of CBS reduction of a bis-oxazolyl ketone using
catecholborane has been reported: Chittari, P.; Yasumasa, H.;
Shiori, T. Synlett 1998,1022.
(17) (S)-Cizolirtine was obtained in the same manner starting from
(S)-3. For ee determination and physical data of (R)- and (S)-
cizolirtine see reference 2.
(18) Effenberger, F.; Krebs, A. J. Org. Chem. 1984, 49, 4687.
(19) Pinkerton, F. H.; Thames, S. F. J. Heterocycl. Chem. 1972, 9,
67.
(1) (a) Colombo, A.; Parés, J.; Frigola, J. FR. Patent 2613720,
1988; Chem. Abstr. 1989, 111, 97244d. (b) Drug Data Report
1990, 12, 347. (c) Caturla, M.C.; Salomó, J.; Soler, M.;
Martínez, L.; Roser, R. J. Pharmaceut. Biomed. 1991, 9,1181.
(2) Torrens, A.; Castrillo, J. A.; Frigola, J.; Salgado, L.; Redondo,
J. Chirality 1999, 11, 63.
(3) Hueso-Rodríguez, J. A.; Berrocal, J.; Gutiérrez, B.; Farré, A.;
Frigola, J. Bioorg. Med. Chem. Lett. 1993, 3, 269.
(4) (a) Itsuno, S.; Ito, K.; Hirao, A.; Nakahama, S. J. Chem. Soc.,
Chem. Commun. 1983, 469. (b) Itsuno, S.; Ito, K.; Hirao, A.;
Nakahama, S. J. Chem. Soc. Perkin Trans. 1 1984, 2887. (c)
Itsuno, S.; Nakano, M.; Miyazaki, K.; Masuda, H.; Ito, K.;
Hirao, A.; Nakahama, S. J. Chem. Soc. Perkin Trans. 1 1985,
2039.
(5) (a) Corey, E. J.; Bakshi, R. K.; Shibata, S. J. J. Am. Chem. Soc.
1987, 109. 5551. (b) Corey, E. J.; Bakshi, R. K.; Shibata, S. J.;
Chen, C.-P.; Singh, V. K. J. J. Am. Chem. Soc. 1987, 109,
7925. (c) Corey, E. J.; Shibata, S. J.; Bakshi, R. K. J. Org.
Chem. 1988, 53, 2861.
(6) For reviews see: (a) Itsuno, S. In Enantioselective Reduction
of Ketones; Paquette, L. A., Ed.; John Wiley: New York,
Organic Reactions 1998, 52, 395-576. (b) Corey, E. J.; Helal,
C. J. Angew. Chem., Int. Ed. Engl. 1998, 37, 1986. (c) Togni,
A.; Venanzi, L. Angew. Chem., Int. Ed. Engl. 1994, 33, 497.
(d) Deloux, L.; Srebnik, M. Chem. Rev. 1993, 93, 763.
(e)Wallbaum, S.; Martens, J. Tetrahedron: Asymmetry 1992,
3, 1475. (f) Singh, V. K. Synthesis 1992, 605. (g) Corey, E. J.
Pure & Appl. Chem. 1990, 62, 1209.
(7) Nevalainen, V. Tetrahedron:Asymmetry 1991, 2, 429.
(8) Manju, K.; Trehan, S. Tetrahedron:Asymmetry 1998, 9, 3365.
(9) Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1995, 36, 9153.
(10) Some ketones containing a non-heterocyclic nitrogen atom
have been reduced enantioselectively: Quallich, G. J.;
Woodall, T. M. Tetrahedron Lett. 1993, 34, 4145.
(20) For the preparation of racemic compound see: Miyashita, A.;
Kurachi, A.; Matsuoka, Y.; Tanabe, N.; Suzuki, Y.; Iwamoto,
K.; Higashino, T. Heterocycles 1997, 44, 417.
(21) 2-Chlorophenyl 1-methyl-1H-imidazol-5-yl ketone: Regel,
E.; Buechel, K. H. Justus Liebigs Ann. Chem. 1977, 145.
(22) For the preparation of racemic carbinol see: Ashton, M. J.;
Ashford, A.; Loveless, A. H.; Ridell, D.; Salmon, J.;
Stevenson, G. V. W. J. Med. Chem. 1984, 27, 1245.
(23) Agarbal, S. C.; Seshadri, T. R. Tetrahedron 1964, 20, 17.
(24) For a recent example of Phillips condensation starting from
chiral carboxylic acids see: Hussain, S. A.; Sarfaraz, T. B.;
Sultana, N.; Murtaza, N.; Qureshi, I. H. Heterocycles 1990,
31, 1245. For a related procedure see: Ogata, M.; Yoshimura,
T.; Fujii, H.; Ito, Y.; Katsuki, T. Synlett 1993, 728.
(25) Physical data of (R)- a-(1-methyl-1H-benzimidazol-2-yl)- a-
phenylmethanol: mp: 185-188° C; [a]D= +119.1 (c= 1.0,
MeOH).
Article Identifier:
1437-2096,E;1999,0,06,0765,0767,ftx,en;G08599ST.pdf
(11) Corey, E. J.; Helal, C. J. Tetrahedron Lett. 1996, 37, 5675.
(12) Corey, E. J.; Bakshi, R. K. Tetrahedron Lett. 1990, 31, 611.
Synlett 1999, No. 6, 765–767 ISSN 0936-5214 © Thieme Stuttgart · New York